In early August, the FDA issued a Class 2 Device Recall for Visibly’s Online Refraction Vision Test, stating that the company did not receive authorization from the FDA to market the product.

The initiative highlights several key astigmatism symptoms that should prompt individuals to schedule an eye exam with an ...

Please provide your email address to receive an email when new articles are posted on . Described as “a stenopaeic slit refraction system in a binocular telescopic ...

NEWARK, Calif.--(BUSINESS WIRE)--EyeQue®, the leader of smartphone vision testing, announced today the EyeQue VisionCheck 2, the most powerful refraction device available for consumers to test their ...

The vision-screening sector has delivered steady growth over the past several years. One study shows these kiosks can reach ...